Showing results (1-10 of 192) with videos related to
Sort By:
Pageof 20
Pharmacology & Therapeutics|December 1, 1991
Cisplatin resistance in human cancersK J Scanlon, M Kashani-Sabet, T Tone, et al.Biochemical Pharmacology|October 7, 1994
Suppression of H-ras-mediated transformation in NIH3T3 cells by a ras ribozymeT Funato, T Shitara, T Tone, et al.Advances in Enzyme Regulation|January 1, 1992
The utility of an anti-fos ribozyme in reversing cisplatin resistance in human carcinomasT Funato, E Yoshida, L Jiao, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1991
Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothioneinK J Scanlon, L Jiao, T Funato, et al.Cancer Research|February 15, 1994
Suppression of the neoplastic phenotype in vivo by an anti-ras ribozymeM Kashani-Sabet, T Funato, V A Florenes, et al.In Vivo (Athens, Greece)|November 1, 1993
Suppression of EJ cells tumorigenicityT Tone, M Kashani-Sabet, T Funato, et al.Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cellsK J Scanlon, M Kashani-SabetChemotherapy|January 1, 1989
Drug selectivity and membrane transport properties of normal human lymphocytesM Kashani-Sabet, K J ScanlonJournal of Clinical Laboratory Analysis|January 1, 1989
Utility of the polymerase chain reaction in detection of gene expression in drug-resistant human tumorsK J Scanlon, M Kashani-SabetThe Journal of Biological Chemistry|July 5, 1990
Cyclosporin A suppresses cisplatin-induced c-fos gene expression in ovarian carcinoma cellsM Kashani-Sabet, W Wang, K J ScanlonPageof 20